Sclerostin antibody, Unconjugated, Rabbit, Polyclonal

Artikelnummer: BYT-ORB100911-IH
Artikelname: Sclerostin antibody, Unconjugated, Rabbit, Polyclonal
Artikelnummer: BYT-ORB100911-IH
Hersteller Artikelnummer: orb100911
Alternativnummer: BYT-ORB100911-100
Hersteller: Biorbyt
Wirt: Rabbit
Kategorie: Antikörper
Applikation: ELISA, IHC-P, WB
Immunogen: KLH conjugated synthetic peptide derived from human Sclerostin. Please contact us for the exact immunogen sequence. The peptide is available as orb374806.
Konjugation: Unconjugated
Alternative Synonym: Anti BEER antibody, anti CDD antibody, anti Sclerosteosis antibody, anti SOST antibody, anti VBCH antibody
Sclerostin antibody
Klonalität: Polyclonal
Konzentration: - 100 µg (in 200 µl): 0.5 mg/ml- 200 µg (in 400 µl): 0.5 mg/ml
Molekulargewicht: 24 kDa
NCBI: 079513
Pubmed: 32404873
UniProt: Q99P68
Reinheit: Polyclonal antibodies are purified by peptide affinity chromatography
Formulierung: 10 mM PBS, 0.02% sodium azide
Target-Kategorie: Sclerostin
Application Verdünnung: IHC-P: 1:100-300, WB: 1:200-1000
IHC-P image of mouse lung tissue using anti-Sclerostin (2.5 ug/ml)
IHC-P staining of mouse bone marrow tissue using Sclerostin antibody (2.5 ug/ml)
Immunohistochemical staining of mouse lung tissue using anti-Sclerostin (2.5 ug/ml)
Immunohistochemical staining of paraffin embedded mouse bone marrow tissue using anti-Sclerostin (2.5 ug/ml)
Western blot analysis of rat kidney (lane 1), mouse liver (lane 2), mouse lung (lane 3), mouse spinal cord (lane 4), hela cells (lane 5), human breast cancer (lane 6) using Sclerostin antibody (1 ug/ml)
WB analysis of human thyroid cancer (lane 1), human endometrial cancer (lane 2), human mammary fibroma (lane 3), human breast cancer (lane 4) using Sclerostin antibody (1 ug/ml)
Western blot analysis of rat kidney (lane 1), mouse liver (lane 2), mouse lung (lane 3), mouse spinal cord (lane 4), hela cells (lane 5), human breast cancer (lane 6) using Sclerostin antibody (1 ug/ml)
WB analysis of human thyroid cancer (lane 1), human endometrial cancer (lane 2), human mammary fibroma (lane 3), human breast cancer (lane 4) using Sclerostin antibody (1 ug/ml)